We are live on ! Find out more
KCPG

Kavar Capital Partners Group Portfolio holdings

AUM $812M
1-Year Est. Return 29.76%
This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+29.76%
3 Year Est. Return
+77.21%
5 Year Est. Return
+92.54%
10 Year Est. Return
+280.51%
AUM
$725M
AUM Growth
-$24.5M
Cap. Flow
-$44.1M
Cap. Flow %
-6.08%
Top 10 Hldgs %
40.97%
Holding
197
New
10
Increased
74
Reduced
71
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 15.82%
2 Financials 11.35%
3 Healthcare 9.99%
4 Consumer Staples 6.13%
5 Communication Services 5.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IEMG icon
151
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$297K 0.04%
4,418
+129
+3% +$8.65K
CBSH icon
152
Commerce Bancshares
CBSH
$8.58B
$290K 0.04%
5,545
+1,118
+25% +$58.5K
ISRG icon
153
Intuitive Surgical
ISRG
$133B
$284K 0.04%
502
+6
+1% +$3.19K
EVRG icon
154
Evergy
EVRG
$19.1B
$284K 0.04%
3,915
+12
+0.3% +$910
ORCL icon
155
Oracle
ORCL
$416B
$284K 0.04%
1,456
+74
+5% +$17.6K
ET icon
156
Energy Transfer Partners
ET
$70B
$279K 0.04%
16,900
AEE icon
157
Ameren
AEE
$30.2B
$278K 0.04%
2,785
+16
+0.6% +$1.64K
ACGL icon
158
Arch Capital
ACGL
$33.8B
$274K 0.04%
+13,150
New +$1.2M
IRM icon
159
Iron Mountain
IRM
$37.8B
$263K 0.04%
3,150
-500
-14% -$46.8K
MICC
160
The Magnum Ice Cream Company N.V.
MICC
$11.5B
$262K 0.04%
+16,515
New +$259K
EPD icon
161
Enterprise Products Partners
EPD
$81.6B
$261K 0.04%
8,144
BMY icon
162
Bristol-Myers Squibb
BMY
$130B
$259K 0.04%
4,802
-61
-1% -$2.94K
BNS icon
163
Scotiabank
BNS
$108B
$252K 0.03%
3,414
+14
+0.4% +$952
IBIT icon
164
iShares Bitcoin Trust
IBIT
$47.8B
$250K 0.03%
+5,044
New +$287K
LHX icon
165
L3Harris
LHX
$53.3B
$237K 0.03%
809
+9
+1% +$2.6K
VHT icon
166
Vanguard Health Care ETF
VHT
$18.4B
$237K 0.03%
825
WY icon
167
Weyerhaeuser
WY
$18.6B
$237K 0.03%
+10,000
New +$231K
CRM icon
168
Salesforce
CRM
$158B
$233K 0.03%
879
+18
+2% +$4.47K
CB icon
169
Chubb
CB
$136B
$231K 0.03%
740
ETN icon
170
Eaton
ETN
$174B
$228K 0.03%
717
+12
+2% +$4.25K
GSK icon
171
GSK
GSK
$103B
$225K 0.03%
4,597
-288
-6% -$13.4K
LOW icon
172
Lowe's Companies
LOW
$123B
$225K 0.03%
932
LIN icon
173
Linde
LIN
$226B
$224K 0.03%
525
+3
+0.6% +$1.28K
CL icon
174
Colgate-Palmolive
CL
$74.4B
$222K 0.03%
2,812
+12
+0.4% +$941
SPEM icon
175
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.6B
$222K 0.03%
4,732

Similar funds

Kavar Capital Partners Group's Q4 2025 Portfolio in Review

As of Q4 2025, Kavar Capital Partners Group held 197 positions worth $725M, down 3.3% from $750M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Kavar Capital Partners Group withdrew a net $44.1M in Q4 2025, closing 10 positions and reducing 71 holdings. Its most notable exit was Vanguard Total Bond Market, an estimated $24.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Kavar Capital Partners Group opened a new position in Avantis US Equity ETF worth $1.79M.

  • Kavar Capital Partners Group's largest Q4 2025 buy was Avantis US Equity ETF: 16,023 shares worth $1.79M.
  • Kavar Capital Partners Group added most to Schwab Fundamental US Large Company Index ETF in Q4 2025, an estimated $1.18M increase.
  • Kavar Capital Partners Group's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $1.31M.
  • Kavar Capital Partners Group fully exited Vanguard Total Bond Market in Q4 2025, selling an estimated $24.9M.
  • Kavar Capital Partners Group's ten largest holdings make up 41% of its $725M portfolio in Q4 2025.
  • Kavar Capital Partners Group opened 10 new positions and closed 10 in Q4 2025.
  • Kavar Capital Partners Group's portfolio value fell 3.3% quarter-over-quarter to $725M.

Based on Kavar Capital Partners Group's 13F filing for Q4 2025, filed 20 Jan 2026.